HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017.

AuthorsAlexandra Albertsson-Lindblad, Thorgerdur Palsdottir, Karin E Smedby, Caroline E Weibull, Ingrid Glimelius, Mats Jerkeman
JournalHaematologica (Haematologica) Vol. 107 Issue 3 Pg. 740-743 (03 01 2022) ISSN: 1592-8721 [Electronic] Italy
PMID34788983 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Bendamustine Hydrochloride
  • Prednisone
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bendamustine Hydrochloride (administration & dosage, therapeutic use)
  • Cyclophosphamide (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Humans
  • Lymphoma, Mantle-Cell (diagnosis, drug therapy, epidemiology)
  • Prednisone (administration & dosage)
  • Rituximab (administration & dosage)
  • Sweden (epidemiology)
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: